Contents

PseudohyperkalemiaEdit

Pseudohyperkalemia is a laboratory artifact in which the potassium level measured in a blood sample appears elevated, even though the patient’s in vivo potassium balance is normal. Clinicians encounter this phenomenon most often when a venous blood sample is drawn for routine testing and the measured potassium does not reflect the true physiological situation. Because true hyperkalemia can be life-threatening, recognizing pseudohyperkalemia is essential to avoid unnecessary, potentially dangerous treatments and to prevent overlooking genuine electrolyte disturbances. Understanding the preanalytic factors that contribute to this artifact helps clinicians interpret laboratory results more reliably and to pursue confirmatory testing when appropriate.

In clinical practice, distinguishing pseudohyperkalemia from real hyperkalemia hinges on careful interpretation of laboratory data in the context of the patient’s condition, blood collection and handling, and the specific specimen type used for potassium measurement. The distinction matters for patient safety, test utilization, and overall quality of care.

Pathophysiology

Pseudohyperkalemia results from the release of potassium from blood cells after collection or during sample processing, rather than from the patient’s circulating potassium in life. The most well-recognized situations involve marked increases in circulating cell counts, particularly leukocytosis (high white blood cell counts) or thrombocytosis (high platelet counts). In such cases, the process of clotting (in serum samples) or stress on fragile cells during handling can cause potassium to leak from cells into the serum or plasma, falsely elevating the measured value. Differences between serum and plasma potassium can therefore arise, providing a clue that the elevated value may be artifactual rather than reflective of true hyperkalemia.

  • In patients with extreme leukocytosis (for example, in certain myeloproliferative disorders such as Chronic myeloid leukemia), potassium can be released from white cells during clot formation, leading to higher serum potassium compared with plasma potassium.
  • In patients with thrombocytosis, platelets can release potassium during clot formation, again producing higher serum potassium than plasma potassium.
  • Hemolysis (mechanical or chemical rupture of red blood cells) during phlebotomy or sample processing adds another source of artifactual potassium elevation, contributing to pseudohyperkalemia.

These processes are influenced by how the sample is collected, how long it sits before processing, and what kind of tube and anticoagulant are used. For example, samples collected into tubes that promote clotting or are subjected to rough handling or delays in processing are more prone to artifactual increases in potassium.

Key concepts for understanding the physiology include distinguishing serum from plasma measurements and recognizing that preanalytic conditions can drive in vitro potassium release independently of the patient’s true potassium status. For more basic chemistry and physiology, see Potassium and Hyperkalemia.

Causes and risk factors

  • Marked leukocytosis (e.g., excessive white blood cell counts) with potassium release during clot formation in serum samples.
  • Thrombocytosis (elevated platelet counts) with potassium release during clot formation in serum samples.
  • Hemolyzed specimens due to rough venipuncture, needle trauma, or delayed separation of serum/plasma.
  • Delays between specimen collection and processing, or aggressive sample handling that damages cells.
  • Use of pneumatic tube systems or other transportation methods that jostle samples and promote cell lysis.
  • Certain anticoagulants or collection tubes that interact with potassium measurements in specific testing workflows.
  • Situations where potassium is measured in serum rather than plasma, increasing the likelihood that cell-associated potassium is released during clotting.
  • Population or disease contexts where cell counts are elevated, such as specific hematologic conditions like Chronic myeloid leukemia or other myeloproliferative disorders.

When evaluating suspected pseudohyperkalemia, clinicians often compare potassium values obtained from different specimen types (serum vs plasma) and review complete blood counts (to assess leukocytosis and thrombocytosis). See also discussions of Hemolysis and Venipuncture for related preanalytic factors.

Diagnosis

Diagnosing pseudohyperkalemia starts with recognizing a discrepancy between the patient’s clinical status and the laboratory finding, and then verifying whether the elevation is reproducible and artifact-related. Practical diagnostic steps include:

  • Compare serum potassium with plasma potassium. A meaningful and consistent discrepancy (elevated serum potassium with comparatively normal plasma potassium) supports pseudohyperkalemia, particularly in the setting of marked leukocytosis or thrombocytosis.
  • Review the complete blood count to identify extreme leukocytosis or thrombocytosis as risk factors for artifact.
  • Assess sample quality for hemolysis (visible or index-based signs) and the timeliness of processing. Hemolyzed samples often show elevated potassium due to red cell rupture.
  • Consider repeating the test with careful phlebotomy technique, using a fresh sample drawn into an appropriate tube and promptly processed. In some cases, measuring potassium in an arterial blood gas sample or in plasma collected with specific anticoagulants can help confirm true potassium status.
  • Use the clinical context and, if necessary, corroborate with additional tests or monitoring to determine whether ongoing hyperkalemia is present.

For readers interested in the chemistry of serum and plasma differences, see Serum and Plasma (blood).

Management and clinical practice implications

Accurate interpretation of potassium results is essential to avoid inappropriate interventions while still protecting patient safety. When pseudohyperkalemia is suspected, clinicians should avoid treating based solely on a single elevated serum potassium result and instead pursue confirmatory testing and a careful review of preanalytic factors.

  • Seek confirmation with a repeat sample drawn with meticulous technique, and consider measuring potassium in plasma or via an arterial blood gas when feasible.
  • Review blood counts to assess whether extreme leukocytosis or thrombocytosis could explain a serum/plasma discrepancy.
  • Ensure proper phlebotomy technique: minimize tourniquet time, avoid vigorous shaking of samples, and use appropriate tubes and immediate processing to limit cell damage.
  • If true hyperkalemia remains a concern after confirmation, manage according to established practice guidelines, but avoid unnecessary and potentially harmful interventions if pseudohyperkalemia is not supported by corroborating evidence.

In laboratory practice, awareness of pseudohyperkalemia prompts standardized handling protocols and robust reporting that notes when a result may be artifactual. Understanding the issue also informs discussions about how best to design testing workflows and interpret results in populations at higher risk for such artifacts. For broader discussions of laboratory reliability and preanalytic error, see Preanalytical error and Clinical laboratory.

See also